Novartis AG - Company Profile

Powered by

All the sales intelligence you need on Novartis AG in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Novartis AG fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Novartis AG.

Back to companies

Novartis AG: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

View more

The following section provides information on Novartis AG’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Novartis AG's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Vasant Narasimhan, MD

Chief Executive Officer Senior Management Since: 2018 Age: 50

Mr. Vasant Narasimhan has been the Chief Executive Officer of the company since 2018. Prior to this, he served as the Global Head Drug Development and the Chief Medical Officer of the company. He is also a member of the Executive Committee of Novartis. Mr. Narasimhan held several leadership positions in the development and commercial functions. He also held the position of Global Head of Development of Novartis Pharmaceuticals; and Global Development Head at Novartis Vaccines. In the past, he led the Sandoz biosimilars and oncology injectables business unit. Prior to Novartis, Mr. Narasimhan worked at McKinsey & Company.

Read Hide full bio of Vasant Narasimhan, MD

Mukul Mehta

Chief Financial Officer Senior Management Since: 2026 Age: 53

Mr. Mukul Mehta has been the Chief Financial Officer of the company since March 2026. Prior to this, he served as the Head of Business Planning and Analysis of Digital Finance and Tax; Chief Financial Officer of International Business; Chief Financial Officer of the company's Pharmaceuticals Business. Previously, he served as the Chief Financial Officer of Novartis Business Services; Chief Financial Officer of Pharmaceuticals Europe Business; and Country Chief Financial Officer of France, Poland, and Norway.

Read Hide full bio of Mukul Mehta

Shreeram Aradhye, MD

Chief Medical Officer; President - Global Drug Development Senior Management Since: 2022 Age: 64

Mr. Shreeram Aradhye has been the Chief Medical Officer and President of Global Drug Development of the company since 2022. Prior to this, he served as the Executive Vice President and Chief Medical Officer at Dicerna Therapeutics. Previously, he served as the Executive Vice President & Chief Development Officer at Axcella Health from 2019 to 2020. Mr. Aradhye has served as Global Head, Medical Affairs and Chief Medical Officer of Pharmaceuticals at Novartis from 2017 to 2019 and Global Head of Development Franchise Neuroscience, and the US Head of Development from 2013 to 2017. Mr. Aradhye has served as the Head of Global Clinical Development & Medical Affairs at Biosimilars, Sandoz, Germany from 2009 to 2011.

Read Hide full bio of Shreeram Aradhye, MD

Michelle Weese

Chief Corporate Affairs Officer Senior Management Since: 2023 Age: 56

Ms. Michelle Weese has been the Chief Corporate Affairs Officer of the company since 2023. Prior to this, she served as the Executive Vice President of Corporate Affairs for Bristol Myers Squibb; General Secretary for North America at Danone; and as Chief Executive Officer of strat-igence. Ms. Weese has also served with Mars Inc and currently serves as a Director with Krispy Kreme Inc.

Read Hide full bio of Michelle Weese

Teresa Jose

Chief Audit Officer Senior Management Since: 2025 Age: 58

Ms. Teresa Jose has been the Chief Audit Officer of the company since 2025. Prior to this, she served as the Global Head of Business Planning & Analysis and Digital Finance of the company. Ms. Jose also served as the Chief Financial Officer of the company's Oncology division.

Read Hide full bio of Teresa Jose
Gain a 360-degree view of Novartis AG and make more informed decisions for your business Gain a 360-degree view of Novartis AG and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer